On this page
At a glance / Promise
Our take
Promise’s product page and terms make the refill amount and cadence more visible than an unspecified monthly label. The unresolved pieces include precise route, patient-state eligibility, pharmacy assignment and independent license verification. Read current availability separately from the catalog, and compare published provider terms without turning price clarity into a clinical-quality ranking.
- Published offer
- MOTS-c single injectable; precise injection route unresolved
- Advertised starting price
- MOTS-c $249 first; $299 every 28 days afterward
- Billing basis
- Recurring subscription every 28 days; higher renewal price
- Refund boundary
- Cancellation stops future renewals; processed charges not automatically reversed, shipped medication may be nonrefundable
- State and pharmacy match
- Exact product-state eligibility and dispensing pharmacy/license not independently verified
Useful details
- Explicit first and renewal pricing with 28-day interval
- Care, medication, cold shipping and check-ins described in package
What to weigh
- The repeating amount is higher than the introductory price
- Precise route and product-specific pharmacy/state match remain unresolved
A review of published information, not a treatment experience or a clinical quality rating. Source check: 2026-10-29.
The offer in front of the reader
Promise lists a single MOTS-c injectable product, with a vial quantity described on the page. We did not establish a more precise injection route from the retrieved detail. A package quantity is useful for identifying the product, but it is neither treatment guidance nor evidence of a benefit. Ask for the exact formulation and proposed route before matching an outcome study to the offer.
Two prices and one repeating interval
The displayed first charge is $249 and the ongoing charge is $299 every 28 days. Comparing only the first amount understates the continuing commitment. Over a fixed calendar window, the number of renewals depends on the actual start date. The cost planner can represent that schedule once the provider confirms the selected quote and any charges outside the bundle.
What the care package includes
The product page describes review, prescription, medication, cold shipping and check-ins. The terms describe a temporary payment authorization at submission and capture after clinician approval. Ask who performs follow-up, which pharmacy handles the prescription and whether your state is eligible for this particular product. Broad platform coverage is qualified by treatment-specific restrictions.
A renewal decision is not a study result
A provider’s recurring service does not establish that administered MOTS-c achieves an outcome discussed in a research paper. Endogenous measurements and administered treatment remain different questions. Read the human evidence for the actual intervention and population, then ask the clinician to connect that evidence to the exact proposed preparation. Our review does not evaluate metabolic benefit or recommend treatment.
Understand the way to stop
The terms describe online, email and phone cancellation routes. Receipt stops future renewals, but processed charges are not automatically reversed and shipped medication may be nonrefundable. Ask when the next charge becomes unavoidable and how a changed clinical plan affects the next shipment. The consultation checklist is useful for retaining those answers alongside the scientific questions.
A useful commercial source with limits
Promise’s product page and terms make the refill amount and cadence more visible than an unspecified monthly label. The unresolved pieces include precise route, patient-state eligibility, pharmacy assignment and independent license verification. Read current availability separately from the catalog, and compare published provider terms without turning price clarity into a clinical-quality ranking.
Sources & further reading
Primary research, provider documents and policy sources used in this article. Sources do not endorse this publication.
Source review: 2026-10-29. Provider terms and policy documents can change.